Latocha, K. M.
Løppenthin, K. B.
Østergaard, M.
Jennum, P. J.
Christensen, R.
Hetland, M.
Røgind, H.
Lundbak, T.
Midtgaard, J.
Esbensen, B. A.
Funding for this research was provided by:
Danish Rheumatism Association (R153-A4718)
Rigshospitalet (E-23241-06)
Novo Nordisk Fonden (NNF15OC0018194)
Lundbeckfonden
The Danish Nurses’ Organization
Toyota-Fonden, Denmark
Article History
Received: 9 February 2020
Accepted: 26 March 2020
First Online: 29 May 2020
Ethics approval and consent to participate {24}
: The project was registered on ExternalRef removed on 30 November 2018 (NCT03766100), the Regional Ethics Committee (H-18016081) and the Danish Data Protection Agency (VD-2018-312).Patients will receive written and oral information about the trial to include background, objectives, course, measurements, and potential advantages, risks and adverse effects. Participation in the project is voluntary and requires written informed consent. Participants will be empowered to withdraw their consent at any time during the trial with no consequences for their arthritis treatment.
: The informed consent form is available from the corresponding author on request.
: The authors declare that they have no competing interests.